Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 6 Breast 6 Gastrointestinal 4 Tumor-Agnostic 1 Head & Neck 1 Gynecologic 1 Genitourinary 1 Dermatologic 1 CNS 1

Conditions

Meningeal Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 76 Temozolomide 73 Specimen Handling 49 Radiotherapy 46 Radiosurgery 34 Cyclophosphamide 28 Bevacizumab 26 Radiation 25 pembrolizumab 24 Biopsy 23 Nivolumab 21 Carboplatin 16 fludarabine 14 X-Rays 13 Ipilimumab 13 Surgical Procedures, Operative 12 Lomustine 12 Irinotecan 12 Vincristine 11 Topotecan 11 Cisplatin 11 Blood Specimen Collection 11 dinutuximab 10 trametinib 9 abemaciclib 9 AZD 6244 9 lutetium Lu 177 dotatate 8 Immunoglobulin G 8 Etoposide 8 Doxorubicin 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

patritumab deruxtecan × CNS × 90 days × Clear all

NCT05865990 2026-05-04

TUXEDO-3

MedSIR

Phase 2 Completed

Brain Neoplasms, Breast Neoplasms, Meningeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡